Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Liu A, Alleyne CD, Moss J, Vinson J, Lafferty K, Quintana S, Duenez N, Lopez K, Johannessen D, Fraide A, Buchbinder S, Scott H, Glidden D, Hecht J. Integrating Mobile Text Messaging Pre-Exposure Prophylaxis Navigation Services Into a Home HIV and Sexually Transmitted Infection Self-Testing Program in the United States: Formative Work and Pilot Implementation Study. JMIR Form Res. 2026 Apr 21;10:e83733. doi: 10.2196/83733. PubMed PMID: 42013381; PubMed Central PMCID: PMC13099030.
McMahan VM, Moreno C, Al-Tayyib A, Ma Y, McFarland W, Sey EK, Wilson EC, Liu AY, Coffin PO, Glick SN. Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities. AIDS Behav. 2026 Feb 12;. doi: 10.1007/s10461-026-05034-4. [Epub ahead of print] PubMed PMID: 41678009; PubMed Central PMCID: PMC13098542.
Wilson EC, Myers J, Muñoz Acosta G, Sicro S, Schaeffer E, Alleyne CD, Diaz A, Walker N, Vinson J, Buchbinder S, Scott H, Liu A. Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San Francisco. AIDS Patient Care STDS. 2025 Jul;39(7):257-265. doi: 10.1089/apc.2024.0259. Epub 2025 Jun 6. PubMed PMID: 40474770.
Spinelli MA, Bisom-Rapp E, Heise MJ, Camp C, Appa A, Liu AY, Sassaman K, Shiels M, Mayorga-Munoz F, Chimezie A, Nguyen J, Oskarsson J, Gandhi M. High Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic Population. Clin Infect Dis. 2025 Jun 4;80(5):1139-1142. doi: 10.1093/cid/ciae531. PubMed PMID: 39484783; PubMed Central PMCID: PMC12135906.
Liu AY, Torres TS, Alleyne CD, Vinson J, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Muessig KE, Buchbinder SP, Sullivan P, Hightow-Weidman LB, Scott H. Developing a Novel Mobile App to Support HIV Testing and Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Formative and Technical Pilot Study. JMIR Hum Factors. 2025 May 29;12:e62830. doi: 10.2196/62830. PubMed PMID: 40440084; PubMed Central PMCID: PMC12163352.
Buchbinder SP, Liu AY. CROI 2025: global epidemiology and prevention of HIV and other sexually transmitted diseases. Top Antivir Med. 2025 May 21;33(2):508-535. Review. PubMed PMID: 40472386.
McMahan VM, Pope E, Luna Marti X, Walker J, Liu AY, Coffin PO. Interest in Long-Acting Preexposure Prophylaxis (PrEP) Among Men at Risk for Human Immunodeficiency Virus Who Use Methamphetamine Participating in a Daily, Oral PrEP Adherence Trial in San Francisco, California. Open Forum Infect Dis. 2025 May;12(5):ofaf280. doi: 10.1093/ofid/ofaf280. eCollection 2025 May. PubMed PMID: 40406373; PubMed Central PMCID: PMC12096071.
McCoy K, Mantell JE, Deiss R, Liu A, Bauman LJ, Bonner CP, Vinson J, Buchbinder S. Pre-Exposure Prophylaxis Awareness and Demand Creation: Overlooked Populations and Opportunities to Move Forward. J Acquir Immune Defic Syndr. 2025 Apr 15;98(5S):e170-e180. doi: 10.1097/QAI.0000000000003626. PubMed PMID: 40163069; PubMed Central PMCID: PMC12256081.
Mantell JE, Bauman LJ, Bonett S, Buchbinder S, Hoffman S, Storholm ED, McCoy K, Rael CT, Cowan E, Gonzalez-Argoti T, Safa H, Scott H, Murtaugh KL, Wilson NL, Liu A. Innovation in Providing Equitable Pre-exposure Prophylaxis Services in the United States: Expanding Access in Nontraditional Settings. J Acquir Immune Defic Syndr. 2025 Apr 15;98(5S):e156-e169. doi: 10.1097/QAI.0000000000003610. PubMed PMID: 40163068; PubMed Central PMCID: PMC12987501.
Rodriguez-Diaz CE, Jaramillo J, Santiago-Rivera Y, Harkness A, Cantos VD, Liu A, Buchbinder S, Saldana CS, Gonzalez K, Malavé-Rivera SM, Reyes N, Vinson J, Scott JY, Lanzi RG, Hidalgo B. Language Justice in Implementation Science: Experiences Working With Latinxs to End the HIV Epidemic. J Acquir Immune Defic Syndr. 2025 Apr 15;98(5S):e104-e110. doi: 10.1097/QAI.0000000000003630. PubMed PMID: 40163061; PubMed Central PMCID: PMC12558689.
Biello KB, Mayer KH, Scott H, Valente PK, Hill-Rorie J, Buchbinder S, Ackah-Toffey L, Sullivan PS, Hightow-Weidman L, Liu AY. The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial. JMIR Public Health Surveill. 2025 Feb 5;11:e63428. doi: 10.2196/63428. PubMed PMID: 39908084; PubMed Central PMCID: PMC11840373.
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R, Global F/TDF PrEP Study Team. Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clin Infect Dis. 2024 Nov 22;79(5):1197-1207. doi: 10.1093/cid/ciae143. PubMed PMID: 38484128; PubMed Central PMCID: PMC7616831.
Velloza J, Liu AY, Katz AWK, van der Straten A, Siegler AJ, Scott H, Wilde G, Lockard A, Christie RH, Buchbinder SP. Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration. AIDS Care. 2024 Nov;36(11):1704-1718. doi: 10.1080/09540121.2024.2397133. Epub 2024 Sep 2. PubMed PMID: 39222964; PubMed Central PMCID: PMC11511627.
Liu AY, Buchbinder SP. CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases. Top Antivir Med. 2024 Jul 17;32(3):447-482. PubMed PMID: 39142289; PubMed Central PMCID: PMC11293602.
Enns B, Sui Y, Guerra-Alejos BC, Humphrey L, Piske M, Zang X, Doblecki-Lewis S, Feaster DJ, Frye VA, Geng EH, Liu AY, Marshall BDL, Rhodes SD, Sullivan PS, Nosyk B, localized economic modelling study group. Estimating the potential value of MSM-focused evidence-based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model-based analysis. J Int AIDS Soc. 2024 Jul;27 Suppl 1(Suppl 1):e26265. doi: 10.1002/jia2.26265. PubMed PMID: 38965982; PubMed Central PMCID: PMC11224592.
Giguere R, Balán IC, Kutner BA, Choi SK, Tingler R, Johnson S, Macagna N, Webster J, Liu A, Chariyalertsak S, Hoesley C, Gonzales P, Ho K, Kayange N, Palanee-Phillips T, Brown E, Zemanek J, Jacobson CE, Doncel GF, Piper J, Bauermeister JA, MTN-035 Protocol Team. History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products. AIDS Behav. 2024 Aug;28(8):2577-2589. doi: 10.1007/s10461-024-04360-9. Epub 2024 May 13. PubMed PMID: 38740628; PubMed Central PMCID: PMC11480948.
Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H, COVID-19 Prevention Network (CoVPN). SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Netw Open. 2024 May 1;7(5):e2412835. doi: 10.1001/jamanetworkopen.2024.12835. PubMed PMID: 38780941; PubMed Central PMCID: PMC11117088.
Liu AY, Alleyne CD, Doblecki-Lewis S, Koester KA, Gonzalez R, Vinson J, Scott H, Buchbinder S, Torres TS. Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial. JMIR Form Res. 2024 Mar 27;8:e54073. doi: 10.2196/54073. PubMed PMID: 38536232; PubMed Central PMCID: PMC11007601.
Liu AY, Gundacker H, Richardson B, Chen BA, Hoesley C, van der Straten A, Brown A, Beamer M, Robinson J, Jacobson CE, Scheckter R, Bunge K, Schwartz J, Thurman A, Piper JM, Marzinke MA, MTN-038 Protocol Team for the Microbicide Trials Network. Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States. J Int AIDS Soc. 2024 Mar;27(3):e26223. doi: 10.1002/jia2.26223. PubMed PMID: 38444118; PubMed Central PMCID: PMC10935712.
Bauermeister J, Lin W, Tingler R, Liu A, Chariyalertsak S, Hoesley C, Gonzales P, Ho K, Kayange N, Phillips TP, Johnson S, Brown E, Zemanek J, Jacobson CE, Doncel GF, Piper J, MTN-035 Protocol Team for the Microbicide Trials Network. A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035. J Int AIDS Soc. 2024 Mar;27(3):e26219. doi: 10.1002/jia2.26219. PubMed PMID: 38494656; PubMed Central PMCID: PMC10945032.
Choi SK, Bauermeister J, Tingler RC, Johnson S, Macagna N, Ho K, Hoesley C, Liu A, Kayange N, Palanee-Phillips T, Chariyalertsak S, Gonzales P, Piper JM, MTN-035 Protocol Team. A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial). BMC Public Health. 2023 Dec 8;23(1):2464. doi: 10.1186/s12889-023-17368-y. PubMed PMID: 38066471; PubMed Central PMCID: PMC10709877.
Liu AY, Scott HM, Buchbinder SP. New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?. JAMA. 2023 Aug 22;330(8):699-701. doi: 10.1001/jama.2023.11700. PubMed PMID: 37606684; PubMed Central PMCID: PMC10586231.
Liu AY, Buchbinder SP. CROI 2023: Epidemiologic Trends and Prevention for HIV and Other Sexually Transmitted Infections. Top Antivir Med. 2023 May;31(3):468-492. PubMed PMID: 37315512; PubMed Central PMCID: PMC10266866.
Bauermeister JA, Dominguez Islas C, Jiao Y, Tingler R, Brown E, Zemanek J, Giguere R, Balan I, Johnson S, Macagna N, Lucas J, Rose M, Jacobson C, Collins C, Livant E, Singh D, Ho K, Hoesley C, Liu A, Kayange N, Palanee-Phillips T, Chariyalertsak S, Gonzales P, Piper J, MTN-035 Protocol Team. A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035). PLoS One. 2023;18(4):e0284339. doi: 10.1371/journal.pone.0284339. eCollection 2023. PubMed PMID: 37043527; PubMed Central PMCID: PMC10096248.
Mitchell KM, Boily MC, Hanscom B, Moore M, Todd J, Paz-Bailey G, Wejnert C, Liu A, Donnell DJ, Grinsztejn B, Landovitz RJ, Dimitrov DT. Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083. Lancet Reg Health Am. 2023 Feb;18:100416. doi: 10.1016/j.lana.2022.100416. eCollection 2023 Feb. PubMed PMID: 36844011; PubMed Central PMCID: PMC9950652.
Buchbinder SP, Siegler AJ, Coleman K, Vittinghoff E, Wilde G, Lockard A, Scott H, Anderson PL, Laborde N, van der Straten A, Christie RH, Marlborough M, Liu AY. Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men. AIDS Behav. 2023 Feb;27(2):719-732. doi: 10.1007/s10461-022-03805-3. Epub 2022 Aug 19. PubMed PMID: 35984607; PubMed Central PMCID: PMC9908647.
Saberi P, Stoner MCD, Ming K, Lisha NE, Hojilla JC, Scott HM, Liu AY, Steward WT, Johnson MO, Neilands TB. The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions. AIDS. 2022 Nov 1;36(13):1783-1789. doi: 10.1097/QAD.0000000000003283. Epub 2022 Jun 22. PubMed PMID: 35730363; PubMed Central PMCID: PMC9529898.
Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu AY, Frank I, Ho K, Santana J, Stekler JD, Chen YQ, McCauley M, Gulick RM, HPTN 069/ACTG 5305 Study Team. Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). AIDS Behav. 2022 Dec;26(12):4107-4114. doi: 10.1007/s10461-022-03736-z. Epub 2022 Jun 10. PubMed PMID: 35687192; PubMed Central PMCID: PMC10265494.
Buchbinder S, Liu A. CROI 2022: epidemiologic trends and prevention for HIV and SARS-CoV-2. Top Antivir Med. 2022 Apr-May;30(2):426-453. PubMed PMID: 36346701; PubMed Central PMCID: PMC9306688.
Stoner MCD, Browne EN, Gundacker HM, Hawley I, Chen BA, Hoesley C, Scheckter R, Piper J, Singh D, Song M, Liu A, van der Straten A. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS One. 2022;17(2):e0263664. doi: 10.1371/journal.pone.0263664. eCollection 2022. PubMed PMID: 35192655; PubMed Central PMCID: PMC8863232.
Hawley I, Song M, Scheckter R, McClure T, Piper J, Chen BA, Hoesley C, Liu AY, van der Straten A. Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials. AIDS Res Hum Retroviruses. 2022 Apr;38(4):313-326. doi: 10.1089/AID.2021.0077. Epub 2022 Feb 11. PubMed PMID: 34969254; PubMed Central PMCID: PMC9048173.
Saberi P, Ming K, Shrestha I, Scott H, Thorson B, Liu A. Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics. Open Forum Infect Dis. 2022 Feb;9(2):ofab657. doi: 10.1093/ofid/ofab657. eCollection 2022 Feb. PubMed PMID: 35087913; PubMed Central PMCID: PMC8789566.
Wilson EC, Turner CM, Sanz-Rodriguez C, Arayasirikul S, Gagliano J, Woods T, Palafox E, Halfin J, Martinez L, Makoni B, Eskman Z, Lin R, Rodriguez E, Rapues J, Pardo S, Liu A. Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area. J Acquir Immune Defic Syndr. 2021 Dec 15;88(S1):S39-S48. doi: 10.1097/QAI.0000000000002809. PubMed PMID: 34757991; PubMed Central PMCID: PMC8579985.
Le Guillou A, Buchbinder S, Scott H, Liu A, Havlir D, Scheer S, Jenness SM. Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):340-347. doi: 10.1097/QAI.0000000000002781. PubMed PMID: 34354011; PubMed Central PMCID: PMC8556308.
Roberts ST, Hawley I, Luecke E, Mensch B, Wagner T, Hoesley C, McClure T, Dominguez Islas CP, Piper JM, Liu AY, van der Straten A. Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial. J Womens Health (Larchmt). 2022 Jul;31(7):1029-1039. doi: 10.1089/jwh.2021.0121. Epub 2021 Oct 19. PubMed PMID: 34665672; PubMed Central PMCID: PMC9299526.
Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016. PubMed PMID: 34379922; PubMed Central PMCID: PMC8448593.
Liu AY, Dominguez Islas C, Gundacker H, Neradilek B, Hoesley C, van der Straten A, Hendrix CW, Beamer M, Jacobson CE, McClure T, Harrell T, Bunge K, Devlin B, Nuttall J, Spence P, Steytler J, Piper JM, Marzinke MA, MTN-036/IPM 047 Protocol Team for the Microbicide Trials Network. Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. J Int AIDS Soc. 2021 Jun;24(6):e25747. doi: 10.1002/jia2.25747. PubMed PMID: 34118115; PubMed Central PMCID: PMC8196716.
Biello KB, Horvitz C, Mullin S, Mayer KH, Scott H, Coleman K, Dormitzer J, Norelli J, Hightow-Weidman L, Sullivan P, Mimiaga MJ, Buchbinder S, Bojan K, Futterman D, Emmanuel P, Liu A. HIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with men. Mhealth. 2021;7:26. doi: 10.21037/mhealth-20-70. eCollection 2021. PubMed PMID: 33898595; PubMed Central PMCID: PMC8063023.
Giovenco D, Muessig KE, Horvitz C, Biello KB, Liu AY, Horvath KJ, Golinkoff JM, Reback CJ, Hightow-Weidman L. Adapting technology-based HIV prevention and care interventions for youth: lessons learned across five U.S. Adolescent Trials Network studies. Mhealth. 2021;7:21. doi: 10.21037/mhealth-20-43. eCollection 2021. PubMed PMID: 33898590; PubMed Central PMCID: PMC8063021.
Buchbinder S, Liu A. CROI 2021: Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research. Top Antivir Med. 2021 Apr-May;29(2):309-327. Review. PubMed PMID: 34107201; PubMed Central PMCID: PMC8224247.
Mitchell KM, Dimitrov D, Silhol R, Geidelberg L, Moore M, Liu A, Beyrer C, Mayer KH, Baral S, Boily MC. The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. Lancet HIV. 2021 Apr;8(4):e206-e215. doi: 10.1016/S2352-3018(21)00022-9. Epub 2021 Feb 19. PubMed PMID: 33617783; PubMed Central PMCID: PMC8045548.
Sudler A, Cournos F, Arnold E, Koester K, Riano NS, Dilley J, Liu A, Mangurian C. The case for prescribing PrEP in community mental health settings. Lancet HIV. 2021 Apr;8(4):e237-e244. doi: 10.1016/S2352-3018(20)30273-3. Epub 2021 Jan 22. PubMed PMID: 33493438.
Seneviratne HK, Hamlin AN, Li S, Grinsztejn B, Dawood H, Liu AY, Kuo I, Hosseinipour MC, Panchia R, Cottle L, Chau G, Adeyeye A, Rinehart AR, McCauley M, Eron JS, Cohen MS, Landovitz RJ, Hendrix CW, Bumpus NN. Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study. ACS Pharmacol Transl Sci. 2021 Feb 12;4(1):226-239. doi: 10.1021/acsptsci.0c00181. eCollection 2021 Feb 12. PubMed PMID: 33615175; PubMed Central PMCID: PMC7888308.
Mitchell KM, Dimitrov D, Hughes JP, Moore M, Vittinghoff E, Liu A, Cohen MS, Beyrer C, Donnell D, Boily MC. Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials. Epidemics. 2020 Dec;33:100423. doi: 10.1016/j.epidem.2020.100423. Epub 2020 Nov 20. PubMed PMID: 33285419; PubMed Central PMCID: PMC7938213.
Saberi P, Ming K, Scott H, Liu A, Steward W. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020;15(10):e0240745. doi: 10.1371/journal.pone.0240745. eCollection 2020. PubMed PMID: 33064763; PubMed Central PMCID: PMC7567425.
Liu AY, Laborde ND, Coleman K, Vittinghoff E, Gonzalez R, Wilde G, Thorne AL, Ikeguchi E, Shafner L, Sunshine L, van der Straten A, Siegler AJ, Buchbinder S. DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men. AIDS Behav. 2021 Apr;25(4):1001-1012. doi: 10.1007/s10461-020-03054-2. Epub 2020 Oct 12. PubMed PMID: 33044687; PubMed Central PMCID: PMC7979437.
Tolley EE, Zangeneh SZ, Chau G, Eron J, Grinsztejn B, Humphries H, Liu A, Siegel M, Bertha M, Panchia R, Li S, Cottle L, Rinehart A, Margolis D, Jennings A, McCauley M, Landovitz RJ. Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077. AIDS Behav. 2020 Sep;24(9):2520-2531. doi: 10.1007/s10461-020-02808-2. PubMed PMID: 32052214; PubMed Central PMCID: PMC7423859.
von Kleist M, García-Lerma JG, Liu A, Anderson PL. Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV. Front Pharmacol. 2020;11:1288. doi: 10.3389/fphar.2020.01288. eCollection 2020. PubMed PMID: 32982729; PubMed Central PMCID: PMC7479819.
Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. The importance of PrEP persistence in preventing HIV infections on PrEP. J Int AIDS Soc. 2020 Aug;23(8):e25578. doi: 10.1002/jia2.25578. PubMed PMID: 32844591; PubMed Central PMCID: PMC7448189.
Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 Jul 14;10(7):e040734. doi: 10.1136/bmjopen-2020-040734. PubMed PMID: 32665393; PubMed Central PMCID: PMC7454188.
What would you like to do?